A randomized clinical trial on<i>n</i>-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

Abstract

We observed a tendency toward reduction in all-cause mortality in the n-3 PUFA groups that, despite a low number of participants, reached borderline statistical significance. The magnitude of risk-reduction suggests that a larger trial should be considered in similar populations.